RE:RE:RE:RE:RE:After 14 years, GET AN IND SUBMISSION IN TO THE FDA!!Sdpp is setting another
deadline trap. The fact is he has no idea what the terms of the Daiichi Sankyo/Bioasis agreement are, including the purpose of the deadline.
The agreement and its deadline could have many meanings as I
posted earlier, including a simple demand from Bioasis to get the work done by a certain date or Bioasis is moving on. In that case, the work could be testing of xB3-001.
I expect no news from it, but there could be, sooner, much later or in between.
jd